Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Huddinge – page 42

745 clinical trials in Huddinge, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Huddinge at a glance
745
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

745 trials in Huddinge

Open in trial search

Non-small cell lung cancer

Not recruiting

Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Vastra Gotalandsregionen

Myasthenia gravis

Not recruiting

Study on the Safety and Tolerability of DNTH103 for Adults with Generalized Myasthenia Gravis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

IgA nephropathy

Not recruiting

Study on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Iptacopan
  • Sponsor:Novartis Pharma AG

Prophylaxis against transplant rejection

Not recruiting

Study on Siplizumab, Cyclophosphamide, and Splenectomy for Preventing Liver Transplant Rejection in Patients Receiving a Deceased Donor Liver

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Siplizumab
  • Sponsor:Itb-Med AB

Plasma cell myeloma refractory

Not recruiting

Study of Teclistamab for Patients with Relapsed or Refractory Multiple Myeloma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Janssen Cilag International

Acute myeloid leukaemia+1

Not recruiting

Study Comparing Gilteritinib and Midostaurin with Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with FLT3 Mutation

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Gilteritinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Migraine

Not recruiting

Study on Rimegepant for Treating Migraine in Adults Who Cannot Use Triptans

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Migraine

Not recruiting

Study on Rimegepant for Preventing Migraines in Adults with Poor Response to Oral Preventive Medications

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Rimegepant
  • Sponsor:Pfizer Inc.

Diabetic retinopathy+1

Not recruiting

Study on the Effectiveness and Safety of BAY 3283142 in Reducing Urine Albumin for Patients with Chronic Kidney Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Bayer AG

Non-small cell lung cancer

Not recruiting

Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Idiopathic inflammatory myopathy

Not recruiting

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Neurodegenerative disorder

Not recruiting

Study of Latozinemab for Patients with Neurodegenerative Diseases Who Previously Participated in a Latozinemab Study

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Latozinemab
  • Sponsor:Alector LLC

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Huddinge

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies exploring treatments for heart failure prevention and cardiovascular disease, including investigations into cholesterol metabolism and blood pressure management.

  • PCSK9 inhibitors and statins research
  • Heart failure prevention trials
  • Lipoprotein management studies

Comprehensive research focusing on reducing cardiovascular events and improving patient outcomes.

02 Oncology Studies

Groundbreaking research in blood cancers, including acute myeloid leukemia and multiple myeloma, with innovative therapeutic approaches.

  • Advanced breast cancer treatments
  • Leukemia therapy combinations
  • CAR T Cell therapy trials

Studies evaluating novel treatment combinations and targeted therapies for various cancer types.

03 Neurological Disorders

Clinical investigations focusing on Alzheimer's disease and amyotrophic lateral sclerosis, exploring innovative therapeutic approaches.

  • Cognitive impairment treatments
  • ALS survival studies
  • Inflammatory response research

Studies examining new therapeutic options for progressive neurological conditions.

04 Chronic Conditions

Research initiatives addressing chronic kidney disease, cystic fibrosis, and other long-term health conditions.

  • Kidney disease management
  • Diabetes treatment studies
  • Organ transplant research

Comprehensive studies aimed at improving quality of life for patients with chronic conditions.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.